Last week, it was exciting to prepare a talk on new developments in nanotechnology for the USPTO. Leading the list of exciting sub-topics was how nanotech is being used for revolutionary fast DNA sequencing, a core aspect of personalized medicine. Recent 977 nanotech patent publications focus on nanopore technology, for example. Semiconductor processing is also being used to integrate with nucleic acid sequencing in revolutionary ways, bringing down the amount of time and money needed for sequencing. Nanotech has always been looking for its “killer app” – fast DNA sequencing could be it for the second decade of the NNI. Time to increase the publicity surrounding this revolution and its source in nanotech.
Related Insights
December 9, 2025
Foley Viewpoints
White House Orders Task Forces To Investigate Food Industry
Last month, we reported on the Department of Justice (“DOJ”) ramping up antitrust enforcement in the agriculture industry, including…
December 8, 2025
Foley Viewpoints
2026 Outlook: AI, IPOs, and the New “Normal” in Venture & Private Equity
Key Takeaways The 2026 outlook for market activity is cautiously optimistic amid ongoing challenges.Private equity firms are shifting to…
December 8, 2025
Labor & Employment Law Perspectives
Colorado Adds New NICU Leave Under FAMLI: What Employers Should Know
Colorado’s Family and Medical Leave Insurance (FAMLI) program has provided employees with paid leave for major life events since 2024,…